6 / 8
Page 31
Notes:
allied
academies
Journal of Medical Oncology & Therapeutics | Volume 4
March 18-19, 2019 | London, UK
Oncology & Cancer Therapy
International Conference on
Selective internal radiation therapy (SIRT) versus Transcatheter arterial chemoembolisation (TACE) in
radiology
Grace Moscatelli
Sydney Hospital, Australia
S
elective Internal RadiationTherapy (SIRT) andTranscatheter
Arterial Chemoembolisation (TACE) are both minimally
invasive procedures performed in the angiography suite by an
Interventional Radiologist. Patients with primary or secondary
liver cancer who are unable to have a surgical resection due
to tumour size, position, multifocality or inadequate hepatic
reserve may be a suitable candidate for a SIRT or TACE
procedure.
Prior to treatment the patient would have baseline imaging
scans followed by a consultation. Once the agreed procedure
is confirmed further tests and information is given to the
patient such as taking blood, ceasing anticoagulants and
fasting details to ensure patient is prepared in a safe and
timely manner. On the day of the procedure a nurse from
the radiology department admits the patient ensuring the
patient is prepared properly for the planned procedure
while in care of the multidisciplinary team.
To commence the image guided procedure local anaesthetic
is administered followed by an arterial puncture on the
femoral artery obtaining access where an access needle
is followed by guidewires and a thin catheter. The doctor
navigates through the patient’s blood vessels by injecting
radiopaque contrast media while breathing instructions are
performed by the patient to acquire clear images identifying
the hepatic artery supplying the liver tumour. This technique
enables liver tumours to be selectively irradiated avoiding the
portal vein supplying normal liver parenchyma minimising
damage to healthy surrounding tissue.
Although these treatments do not permanently cure liver
cancer, the aim is to increase survival time and quality of life.
The patient may have more than one treatment and when
combined with standard chemotherapy survival benefit
increases. As with all procedures it is evident risks are
involved and post procedure complications may also occur.
The risk versus benefit is explained to the patient and any
complications requiring intervention would be treated as
needed.
Speaker Biography
Grace Moscatelli completed her Bachelor of Nursing at University of Western Sydney
and she is currently studying Bachelor of Nursing with Professional Honours Specialising
in Anaesthetic and Recovery Nursing at University of Tasmania. She works at a local
Sydney hospital in Australia as a Registered Nurse in the Radiology, Nuclear Medicine
and PET Department. She has presented at Medical Imaging Nurses Association National
Conference in Melbourne, Australia in 2017, Euro Cancer International Conference in
Rome, Italy in 2018 and Annual Biomarkers Congress in Osaka, Japan in 2018.
e
:
grace.moscatelli@health.nsw.gov.au